July 23, 2012 - The Food and Drug Administration is expected to announce that it will approve the obesity drug Qnexa. If approved, it would be the first new diet drug to hit the market in more than a decade. Research shows the drug can help people lose weight, reduce diabetes and lower blood pressure. But there are safety concerns, there's evidence it can cause a patient's heart rate to quicken and may also increase the risk of cleft lip in babies when pregnant women take the drug.
Also, according to a new study, women who give birth to heavy babies are twice as likely to develop breast cancer. Researchers in Texas found women who delivered babies over eight pounds had higher hormone levels which can increase the risk of breast cancer. According to the researchers, larger infants appear to foster certain levels of hormones during pregnancy that increase a woman's risk of cancer. Doctors say breast feeding, exercising and eating a healthy diet can lower womens cancer risk. The study was published in the journal PLoS One.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.